BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3046895)

  • 1. [Immunodiagnostic findings in patients with kala-azar].
    Mannweiler E; Lederer I; Feldmeier H
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An indirect fluorescent antibody (IFA) test for the serodiagnosis of Kala-Azar.
    Choudhry A; Puri A; Guru PY; Saxena RP; Saxena KC
    J Commun Dis; 1992 Mar; 24(1):32-6. PubMed ID: 1296950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
    Kohanteb J; Rezai HR; Ardehali S
    J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar.
    Salotra P; Raina A; Negi NS
    Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis in Somalia. Circulating antibodies as measured by DAT, immunofluorescence and ELISA.
    Shiddo SA; Mohamed AA; Huldt G; Loftenius A; Nilsson L; Jonsson J; Ouchterlony O; Thorstensson R
    Trop Geogr Med; 1995; 47(2):68-73. PubMed ID: 8592766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of anti-Leishmania antibodies in parenteral drug addicts. Yield value of 2 study techniques].
    GutiƩrrez J; Maroto MC; PiƩdrola G; Higuera A
    Med Clin (Barc); 1993 Feb; 100(5):168-70. PubMed ID: 8450694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis.
    Kumar D; Srividya G; Verma S; Singh R; Negi NS; Fragaki K; Kubar J; Salotra P
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):167-71. PubMed ID: 18177681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect fluorescent antibody test in the serodiagnosis of visceral leishmaniasis in Bangladesh.
    Muazzam N; Rahman KM; Miah RA; Asna SM
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):77-81. PubMed ID: 1303085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bulk production and comparison of promastigote and amastigote antigens of Leishmania donovani for serodiagnosis and value of serum protein and immunoglobulin changes in diagnosis of kala-azar cases.
    Dutta GD; Dutta GP
    J Commun Dis; 1985; 17(1 Suppl):77-82. PubMed ID: 3831071
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients.
    Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Gupta PN; Saha SK; Ali N
    Clin Diagn Lab Immunol; 1999 Mar; 6(2):231-5. PubMed ID: 10066659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological findings in kala-azar, Iran.
    Behforouz NC; Amirhakimi GH; Rezai HR; Saberi MS
    Trop Geogr Med; 1983 Mar; 35(1):27-32. PubMed ID: 6612770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of IgG3 and IgG4 subclass in paediatric cases of kala azar.
    Ansari NA; Kumar R; Raj A; Salotra P
    Parasite Immunol; 2008 Aug; 30(8):403-9. PubMed ID: 18466200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Visceral leishmaniasis contracted in Europe (kala-azar)].
    Reincke M; Allolio B; Hackenberg E; Cohen S; Winkelmann W; Kaufmann W
    Med Klin (Munich); 1990 Apr; 85(4):220-3. PubMed ID: 2191212
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative evaluation of serological tests in Indian kala-azar.
    Sinha R; Sehgal S
    J Trop Med Hyg; 1994 Dec; 97(6):333-40. PubMed ID: 7966534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid accurate field diagnosis of Indian visceral leishmaniasis.
    Sundar S; Reed SG; Singh VP; Kumar PC; Murray HW
    Lancet; 1998 Feb; 351(9102):563-5. PubMed ID: 9492776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic problems of kala azar in non-endemic area.
    Datta U; Gupta S; Arora S; Sehgal S
    Indian J Pathol Microbiol; 1987 Jan; 30(1):23-9. PubMed ID: 3315993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.